Medtech Big 100: Just missed the list
No. 101: Glaukos
Revenue: $282,862,000
R&D expenditures: $123,271,000
Employees: 783
CEO: Thomas Burns
HQ: Aliso Viejo, California
www.glaukos.com
Glaukos ranked No. 95 in our 2022 Medtech Big 100 with $294 million in sales. Its drop from the 2023 ranking can be attributed to newcomers to the list and a decrease in its own sales. Glaukos develops ophthalmic medical devices for treating glaucoma, corneal disorders and retinal disease.
Medtech Big 100 analysis: Sales grow, jobs decrease, R&D spending climbs